Codexis Inc (CDXS): יחס שווי שוק להכנסות
On GURU.Markets, the P/S divergence from the historical average demonstrates market expectations, where the value of 1.40 serves as the current indicator. The Codexis, Inc. (CDXS) business is exposed to risks due to its dependence on major customers and lengthy development cycles. However, the CodeEvolver platform makes their expertise indispensable, reducing costs for partners. An impeccable reputation as a biocatalysis leader ensures the company maintains the full trust of global pharma behemoths.
פילוחים אנליטיים של חברת Codexis, Inc. (CDXS)
The P/S multiple determines the market value of one dollar of revenue, allowing for an assessment of the business premium regardless of current earnings. The price-to-sales ratio trend reflects market confidence in the commercialization of the R&D pipeline of Codexis, Inc. (CDXS), where any decline in the indicator may signal decreasing demand for engineered enzymes within the biopharmaceutical sector.
